IRTC — iRhythm Holdings, Share Price
0.000.00%
Last trade - 00:00- $4.32bn
- $4.39bn
- $747.14m
- 76
- 11
- 86
- 61
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 29.66 | ||
| Price to Tang. Book | 29.83 | ||
| Price to Free Cashflow | 131.23 | ||
| Price to Sales | 6.06 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -6.61% | ||
| Return on Equity | -36.57% | ||
| Operating Margin | -7.68% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 322.82 | 410.92 | 492.68 | 591.84 | 747.14 | 876.07 | 1,015.68 | 23.02% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
iRhythm Holdings, Inc. is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. The Company's principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. The Company provides Zio ambulatory cardiac monitoring services, including long-term continuous monitoring (LTCM), short-term continuous monitoring, and mobile cardiac telemetry (MCT) monitoring services, using a proprietary system that combines an FDA-cleared and CE-marked wire-free, patch-based, 14-day wearable biosensor that continuously records ECG data, with a proprietary FDA-cleared, CE-marked, Japan PDMA approved cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Directors
- Abhijit Talwalkar NEC (57)
- Quentin Blackford PRE (43)
- Douglas Devine CFO (51)
- Daniel Wilson EVP (39)
- Mark Day EVP (50)
- Patrick Murphy GCN (42)
- David Vort OTH (55)
- Karen Ling DRC (57)
- Bruce Bodaken IND (69)
- Renee Budig IND (60)
- Kevin King IND (64)
- Cathleen Noel Merz IND (65)
- Mark Rubash IND (64)
- Ralph Snyderman IND (81)
- Last Annual
- December 31st, 2025
- Last Interim
- December 31st, 2025
- Incorporated
- December 19th, 2025
- Public Since
- October 20th, 2016
- No. of Shareholders
- 490
- No. of Employees
- 2,400
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 32,316,760
- Address
- 699 8th Street, Suite 600, SAN FRANCISCO, 94103
- Web
- Phone
- +1 6506325700
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for IRTC
Q1 2026 iRhythm Holdings, Inc Earnings Release
iRhythm Technologies Inc Annual Shareholders Meeting
Q2 2026 iRhythm Holdings, Inc Earnings Release
Similar to IRTC
10X Genomics
NASDAQ Global Select Market
Accuray
NASDAQ Global Select Market
Align Technology
NASDAQ Global Select Market
Alphatec Holdings
NASDAQ Global Select Market
Angiodynamics
NASDAQ Global Select Market
FAQ
What is the iRhythm Holdings, share price?
As of Today at 20:23 UTC, shares in iRhythm Holdings, are trading at $140.18. This share price information is delayed by 15 minutes.
How has the iRhythm Holdings, share price performed this year?
Shares in iRhythm Holdings, last closed at $140.18 and the price had moved by +28.11% over the past 365 days. In terms of relative price strength the iRhythm Holdings, share price has outperformed the S&P500 Index by +8.69% over the past year.
What are the analyst and broker recommendations for iRhythm Holdings,?
The overall consensus recommendation for iRhythm Holdings, is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the iRhythm Holdings, dividend yield?
iRhythm Holdings, does not currently pay a dividend.
Does iRhythm Holdings, pay a dividend?
iRhythm Holdings, does not currently pay a dividend.
When does iRhythm Holdings, next pay dividends?
iRhythm Holdings, does not currently pay a dividend.
How do I buy iRhythm Holdings, shares?
To buy shares in iRhythm Holdings, you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of iRhythm Holdings,?
As of the previous close price of $140.18, shares in iRhythm Holdings, had a market capitalisation of $4.32bn.
Where are iRhythm Holdings, shares listed?
Here are the trading details for iRhythm Holdings,:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: IRTC
What kind of share is iRhythm Holdings,?
Based on an overall assessment of its quality, value and momentum iRhythm Holdings, is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a iRhythm Holdings, share price forecast for 2026?
The analyst consensus target price for shares in iRhythm Holdings, is $222.94. That is 59.04% above the last closing price of $140.18.
Analysts covering iRhythm Holdings, currently have a consensus Earnings Per Share (EPS) forecast of -$0.27 for the next financial year.
Find out moreWhat is the trend in the iRhythm Holdings, share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like iRhythm Holdings,. Over the past six months, its share price has underperformed the S&P500 Index by -23.42%.
As of the last closing price of $140.18, shares in iRhythm Holdings, were trading -13.67% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the iRhythm Holdings, PE Ratio?
The iRhythm Holdings, PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $140.18.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of iRhythm Holdings,?
iRhythm Holdings,'s management team is headed by:
- Abhijit Talwalkar - NEC
- Quentin Blackford - PRE
- Douglas Devine - CFO
- Daniel Wilson - EVP
- Mark Day - EVP
- Patrick Murphy - GCN
- David Vort - OTH
- Karen Ling - DRC
- Bruce Bodaken - IND
- Renee Budig - IND
- Kevin King - IND
- Cathleen Noel Merz - IND
- Mark Rubash - IND
- Ralph Snyderman - IND